BSX
Boston Scientific
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BSX
- PEG Ratio
As of Jun 22, 2026, BSX's PEG ratio of 0.25 reflects its valuation relative to its growth rate. This result reflects a P/E ratio of 18.39 measured against EPS growth of 74.6%. When benchmarked against the trailing 4-quarter average of 0.97, BSX's PEG ratio reflects a 74% decrease.
BSX PEG ratio history
Boston Scientific's ten years historical PEG ratio averages out to 1.61. Compared to historical data, BSX's 0.25 PEG ratio represents a decrease of 84%. BSX hit its maximum PEG ratio of 17.01 during the Jun 2023 quarter over the last ten years. The Dec 2018 quarter marked the lowest reading at 0.02, indicating the most attractive growth-adjusted valuation.
Boston Scientific PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.88 | 48.65 | 55.6% |
| 2024 | 4.24 | 70.89 | 16.7% |
| 2023 | 0.38 | 53.53 | 140% |
| 2022 | N/A | 102.82 | -34.8% |
| 2021 | 0.06 | 61.57 | 962.5% |
| 2020 | N/A | N/A | -102.4% |
| 2019 | 0.07 | 13.38 | 179.3% |
| 2018 | 0.02 | 29.21 | 1,412.5% |
| 2017 | N/A | 309.88 | -69.2% |
| 2016 | 0.34 | 83.19 | 244.4% |
| 2015 | N/A | N/A | -100% |
| 2014 | N/A | N/A | 0% |
| 2013 | N/A | N/A | 96.9% |
| 2012 | N/A | N/A | -1,096.6% |
| 2011 | 0.13 | 18.41 | 141.4% |
Boston Scientific PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.35 | 26.04 | 74.6% |
| Dec 2025 | 0.88 | 48.65 | 55.6% |
| Sep 2025 | 0.94 | 51.66 | 54.9% |
| Jun 2025 | 1.7 | 63.18 | 37.1% |
| Mar 2025 | 4.87 | 73.1 | 15% |
| Dec 2024 | 4.24 | 70.89 | 16.7% |
| Sep 2024 | 1.41 | 68.69 | 48.8% |
| Jun 2024 | 0.58 | 62.1 | 106.7% |
| Mar 2024 | 0.55 | 57.08 | 103.4% |
| Dec 2023 | 0.38 | 53.53 | 140% |
| Sep 2023 | 0.64 | 64.39 | 100% |
| Jun 2023 | 17.01 | 90.15 | 5.3% |
| Mar 2023 | 6.28 | 84.8 | 13.5% |
| Dec 2022 | N/A | 102.82 | -34.8% |
| Sep 2022 | N/A | 94.46 | -46.8% |
BSX average PEG ratio chart
BSX's PEG ratio today comes in under the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 0.25, BSX ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.55, Boston Scientific's PEG is 55% lower.
BSX EPS growth
BSX Price vs fair value
BSX PEG vs peers
Among its peer stocks SYK and MDT, BSX's PEG ratio comes in lower.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 0.25 | $65.89B |
| SYK Stryker Corp | 2.11 | $116.81B |
| MMSI Merit Medical Systems Inc | 2.28 | $3.97B |
| MDT Medtronic plc | 6.41 | $101.47B |
| EW Edwards Lifesciences Corp | N/A | $49.45B |
| TFX Teleflex Inc | N/A | $5.39B |
| ANGO Angiodynamics Inc | N/A | $511.94M |
| CNMD CONMED Corp | N/A | $979.75M |
Frequently asked questions
What is Boston Scientific's PEG ratio?
BSX has a PEG ratio of 0.25, per Jun 22, 2026 data.
What is the 3-year average PEG ratio for Boston Scientific (BSX)?
BSX's 3-year PEG ratio average comes in at 2.8.
What is the 5-year average PEG ratio for Boston Scientific (BSX)?
BSX's 5-year PEG ratio average comes in at 2.59.
What is the highest PEG ratio for BSX?
The Jun 2023 quarter marked the ten years high at 17.01 for BSX's PEG ratio.
How does the current PEG ratio for BSX compare to its historical average?
At present, BSX's PEG ratio runs 84% lower than its 10-year historical average.
Why is Boston Scientific's PEG ratio so low?
Strong earnings growth relative to valuation results in BSX's low PEG ratio of 0.25.
How is BSX's PEG ratio calculated (Boston Scientific PEG ratio formula)?
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 22, 2026, Boston Scientific carries a PE ratio of 18.39. Earnings grew at 74.6% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 0.25. PEG RATIO(0.25) = PE RATIO(18.39) / EPS GROWTH(74.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.